When thinking of a biotech market mover Paradigm Biopharmaceuticals (ASX: PAR) instantly comes to mind. Paradigm, through its repurposed drug Zilosul, aims to alleviate the suffering and cartilage degradation of Osteoarthritis. PAR’s impressive clinical developments in osteoarthritis and 240% surge in 2019 captivated both the scientific and investment world. Paradigm kickstarted 2020 off with a […]
Tag Archives: Australian Financial Review
Tesla predicted to hit $7000 by 2024 says ARK Investment Management
Before I start, I am obliged to remind our viewers that this is not advice only general commentary from my extensive research in this area. Tesla’s recent share price surge may only be the start, according to ARK Investment Management. A recent price target set by ARK shows some very opportunistic views on Tesla’s future […]
An $800 investment in Amazon at IPO would now be worth over $1,000,000
Before I start, I am obliged to remind our viewers that this is not advice only general commentary from my extensive research in this area. Amazon is currently priced at $1,861.64 (AMZN), a 120,000% price increase since it’s IPO in 1997. Amazon’s come up is nothing short of remarkable, with the distribution giant reaching $1 […]
PAR on the rise with a strong 6 month growth of 120%
Before I start, I am obliged to remind our viewers that this is not advice only general commentary from my extensive research in this area. Paradigm Co (PAR:ASX) has been one of our top performing stocks which we’ve been closely following since we started Youth Investment Group. We first noticed Paradigm bouncing around $1.85 and saw it’s […]
How I would invest $100,000 today for 2020 results
Let’s say an investment firm has given you $100,000 to invest in the ASX to make a substantial return by EOY 2020. How would you set up your portfolio for 2020? You have been asked to make a solid return over a 1 year period, which is generally a short time frame for stock price growth. […]
Is it worth shutting the gate on CAN after their 60% plummet?
Before I start, I am obliged to remind our viewers that this is not advice only general commentary from my extensive research in this area. CAN The Australian medicinal cannabis market is speculative, volatile, and dependent on the anticipated growth in demand. Cann Group Limited’s recent plummet captures the current market conditions perfectly. The key […]
Are stapled vehicles a promising property investment?
So far YIG has released articles pertaining to Investment properties and AREITS, AREIT Goodman Group. Today we will be breaking down the components of a stapled vehicle. A stapled vehicle is a type of internal management. So why call it stapled? Because the two investment vehicles being a Trust and a company is bound […]
Why did NHL skyrocket by 1100% in 2 weeks?
Before I start, I am obliged to remind our viewers that this is not advice only general commentary from my extensive research in this area. The therapeutic landscape is changing. Now applications on iPhones are being used to treat medical illnesses. Who would have thought? Novita healthcare (NHL) is an Australian medical technology company. Novita […]
Investment properties – One of the keys to financial freedom ?
Before I start, I am obliged to remind our viewers that this is not advice only general commentary from my extensive research in this area. Introduction: Property Investment The phrase ‘investmentproperty’ is considered a milestone for young investors. Primarily, because of Australia’sbooming increase in property prices within the past decade. Many of us (youth) doubt […]
Cann Group losing value as bearish market trend sets in – How much more will investors take?
Before I start, I am obliged to remind our viewers that this is not advice only general commentary from my extensive research in this area. Introduction Cann Group (CAN) Cann Group (CAN) is an Australian medicinal cannabis company. Cann aims to research, cultivate, and manufacture a range for medicinal cannabis products for patients in Australia […]